Paul Edward Walker's Net Worth

$69 Million

Who is Paul Edward Walker?

Paul Edward Walker has an estimated net worth of $69 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., Allakos Inc., Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Metacrine, Inc., Trillium Therapeutics Inc., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Marker Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., Regulus Therapeutics Inc., and Korro Bio, Inc..

SEC CIK

Paul Edward Walker's CIK is 0001553150

Past Insider Trading and Trends

2021 was Paul Edward Walker's most active year for acquiring shares with 16 total transactions. Paul Edward Walker's most active month to acquire stocks was the month of May. 2021 was Paul Edward Walker's most active year for disposing of shares, totalling 16 transactions. Paul Edward Walker's most active month to dispose stocks was the month of May. 2022 saw Paul Edward Walker paying a total of $370,199,679.40 for 11,001,816 shares, this is the most they've acquired in one year. In 2020 Paul Edward Walker cashed out on 7,601,248 shares for a total of $14,612,730.78, their largest year based on trade value.